Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 25:16:2837-2842.
doi: 10.2147/OPTH.S372633. eCollection 2022.

Ocular Features and Clinical Approach to Cataract and Corneal Refractive Surgery in Patients with Myotonic Dystrophy

Affiliations

Ocular Features and Clinical Approach to Cataract and Corneal Refractive Surgery in Patients with Myotonic Dystrophy

Majid Moshirfar et al. Clin Ophthalmol. .

Abstract

Myotonic dystrophy is the most common inherited muscular dystrophy in adults and presents as two forms, type 1, and type 2. Ocular manifestations such as premature cataract formation, may be the first diagnostic sign or symptom of the disease, offering ophthalmologists a unique diagnostic role. Fuchs' endothelial corneal dystrophy, ptosis and ocular melanoma are other possible findings. Systemic features can help providers better understand the disease and any accommodations to be made in clinical or surgical settings. Some patients with this disease may request evaluation of certain cataract or corneal refractive procedures. This article focuses on pertinent information for clinicians to utilize when evaluating and treating patients with myotonic dystrophy and specific surgical perspectives to consider prior to any ocular interventions. Hydrophobic intraocular lenses are still recommended in these patients with careful observation of capsular phimosis and posterior capsular opacities.

Keywords: IOL; LASIK; SMILE; YAG; capsulotomy; corneal endothelium; intraocular lens; laser assisted in situ keratomileusis; small incision lenticule extraction; yttrium aluminum garnet.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

References

    1. Thornton CA. Myotonic Dystrophy. Neurol Clin. 2014;32(3):705–719. doi:10.1016/j.ncl.2014.04.011 - DOI - PMC - PubMed
    1. Mishra SK, Singh S, Lee B, Khosa S, Moheb N, Tandon VA. “Dystrophia Myotonica” and the Legacy of Hans Gustav Wilhelm Steinert. Ann Indian Acad Neurol. 2018;21(2):116–118. doi:10.4103/aian.AIAN_182_17 - DOI - PMC - PubMed
    1. Meola G, Cardani R. Myotonic Dystrophy Type 2: an Update on Clinical Aspects, Genetic and Pathomolecular Mechanism. J Neuromuscular Dis. 2015;2(s2):S59–S71. doi:10.3233/JND-150088 - DOI - PMC - PubMed
    1. Winchester C. Characterization of the expression of DMPK and SIX5 in the human eye and implications for pathogenesis in myotonic dystrophy. Hum Mol Genet. 1999;8(3):481–492. doi:10.1093/hmg/8.3.481 - DOI - PubMed
    1. Gargallo-Benedicto A, Pérez-Torregrosa VT, Clemente-Tomás R, Duch-Samper AM. Dual corneal involvement by endothelial and epithelial corneal dystrophies in Steinert’s disease: a case of triple dystrophy. Eur J Ophthalmol. 2021;31(2):NP23–NP6. doi:10.1177/1120672119872374 - DOI - PubMed

LinkOut - more resources